The single-use syringe market is experiencing significant momentum globally due to a surge in healthcare demand, rising infection control measures, and expanding vaccination programs. These syringes, ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s ARGX Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and hyaluronidase ...